Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Above 50 Day Moving Average – Time to Sell?

Cipher Pharmaceuticals Inc. (TSE:CPH) (NASDAQ:CPHR) shares passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$15.16 and traded as high as C$16.90. Cipher Pharmaceuticals shares last traded at C$16.83, with a volume of 18,162 shares traded.

Cipher Pharmaceuticals Trading Up 3.8%

The firm has a market cap of C$437.87 million, a price-to-earnings ratio of 16.50 and a beta of 1.33. The firm’s 50-day moving average is C$15.23 and its 200-day moving average is C$15.00. The company has a current ratio of 1.12, a quick ratio of 2.67 and a debt-to-equity ratio of 4.36.

About Cipher Pharmaceuticals

Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products, mainly in dermatology. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products in Canada, the U.S., and South America.